Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.

Lee JJ, Chan A, Tang T.

Acta Oncol. 2016;55(4):519-20. doi: 10.3109/0284186X.2015.1125017. Epub 2016 Jan 12. No abstract available.

PMID:
26754959
2.

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma.

Lee JJX, Chan JJ, Choo SP.

Diseases. 2015 Oct 28;3(4):306-324. doi: 10.3390/diseases3040306. Review.

Supplemental Content

Loading ...
Support Center